$B#6#2#2!'Ev=i!$2hA|E*$KE>0\@-GY4b5?$$$H$5$l$?(B1$BNc(B $B;TN):fIB1!!!IBM}!&8&5f2J(B(1)$B!"8F5[4oFb2J(B(2)$B!"Bg:eO+:RIB1!!!IBM}2J(B(3) $BOBEDD> |
|
$BEjI<7k2L(B 10$B!!(B $B!!(B |
Metastatic endometrial stromal sarcoma |
$B8!F$7k2L(B |
Metastatic endometrial stromal sarcoma |
$B>INc(B | 60$B:MBeA0H>!$=w@-(B |
---|---|
$B7P2a(B |
$B!Z4{1}Nr![(B50$B:MBeA0H>!$;R5\Fy
$B!Z8=IBNr(I%$B8=>I![(B9$B$+7nA0$h$j31SV(B($B4%@-(B)$B$,$"$j!$(B3$BF|A0$+$i1&B&J"ItDK$b=P8=$7!$Ev1!Fb2J30Mho1"1FG'$a!$6;It(BCT$B$K$FE>0\@-GY4b5?$$$H$5$l!$B$1F(BCT$B$K$F@:::M=Ls$5$l$?!%$7$+$7!$6a=j$GI>H=$NK?Am9gIB1!$G?G;!$r4uK>$5$l!$Ev1!$h$j>R2p!%$=$N8e!$K?Am9gIB1!$K$FB$1F(BCT$B;#1F8e!$F~1!$H@:::$r4+$a$i$l$?$,!$=t;v>p$K$h$j!$Ev1!$G$NF~1!!$@:::$r4uK>$5$l!$(B2$B%v7n8e$K8F5[4oFb2JF~1!!%F~1!MbF|$K7PHiE*GY@88!;\9T!%(B50$B:MBeA0H>!$(BA$BIB1!$G $B!ZIBM}AH?%3XE*=j8+![%/%m%^%A%sNL$,Hf3SE*B?$$N`1_7A!AMq1_7A!AC;KB?n7A$N3K$rM-$76-3&ITL@NF$JC8L@!AC89%;@@-!A9%;@@-K&BN$r$b$C$?FbKl4V $B!JI8K\$,>.$5$$$?$a!"AH?%A|Ey$O%$%s%?!<%M%C%H8x3+2hA|$r8f;2>H2<$5$$!K(B |
$B$BBPJ*(B1$B!%(B25HE_$BA4BNA|(B$B!"(B$BBPJ*(B10HE_myxoid change$B!"(B$BBPJ*(B10HE_$B9P7d$,:YD9$$7l4I(B$B!"(B$BBPJ*(B10HE_$B@~0]2=$J$$$7>K;R2=(B$B!"(B$BBPJ*(B10HE_$BA#(B$B!"(B$BBPJ*(B10Ki67_1$B!"(B$BBPJ*(B10Ki67_2$B!"(B$BBPJ*(B10PgR$B!"(B$BBPJ*(B10Al-blue_myxoid change$B!"(B$BBPJ*(B10CK$B!"(B$BBPJ*(B10EMA$B!"(B$BBPJ*(B10ER$B!"(B$BBPJ*(B20HE_$B$S$^$s@-L)$J(B#C57F2$B!"(B$BBPJ*(B20HE_$B@~0]2=$J$$$7>K;R2=(B$B!"(B$BBPJ*(B20Ag_$B$9$@$lMM(B$B!"(B$BBPJ*(B20CD56(NCAM)$B!"(B$BBPJ*(B20Synaptophysin_#C57F4$B!"(B$BBPJ*(B20vimentin$B!"(B$BBPJ*(B40HE_mitosis1$B!"(B$BBPJ*(B40HE_mitosis2 |
|
$B#6#2#3!'(B$B1&g=It $BEDIm6=Iw2qKLLnIB1!!!NW>2IBM}It(B(1)$B!"5~ETBg3X!! $BBkAc98>;(B1)$B!"9a7nF`JfH~(B1)$B!"N-!!9?GH(B1)$B!"9b66!!Nh(B2)$B!"86!!=EM:(B3)$B!"OBEb2mGn(B4)
|
|
---|---|
$BEjI<7k2L(B 6$B!!(B $B!!!!!!!!(B |
Metastatic carcinoma |
$B8!F$7k2L(B |
Epithelioid sarcoma |
$B>INc(B | $B#5#0:PBe8eH>!$=w@-(B |
$B7P2a(B |
$B!Z $B!Z4{1}Nr![E|G"IB(B $B!Z?&6H![ $B!Z$=$NB>![A!0]9)>l!J<+1D!K(B $B!Z8=IBNr![Ev1!eGYLn$K $B!ZF~1!;~8!::@.@S![!J8!BN8!::@.@S!'>JN,!K(B $B!ZF~1!;~(BMR$B8!::![1&g=ItHi2 $B!ZLdBjE@![IBM}AH?%?GCG(B |
$B623_1.jpg$B!"(B623_2.jpg$B!"(B623_3.jpg |
|
$B#6#2#4!'(B$B>.;y@e $B<"2l0e2JBg3XBh0lIBM}(B (1)$B!"<"2l0e2JBg3XImB0IB1!IBM}It(B(2)$B!"<"2l0e2JBg3X8!::It(B (3)$B!"9qN)IB1!5!9=<"2lIB1!<*I!2J(B(4) $BCfB<1Y;R(B1)$B!"6eEhN<<#(B 2)$B!"2,It1Q=S#2!$(B3)$B!"I~ItN4B'(B $B#1(B)$B!"J!Eg0lEP#4!K(B |
|
---|---|
$B!!!!(B$BEjI<7k2L(B 4$B!!(B $B!!!!!!(B |
Hemangioendothelioma |
$B8!F$7k2L(B |
Alveolar soft part sarcoma |
$B>INc(B | $B#0:PBeA0H>!"=w@-(B |
$B7P2a(B |
$B!Z4{1}Nr![!!FC5-$9$Y$-$3$H$O$J$7!#(B $B!ZNW>27P2a![!!@e $B!ZIBM}Fy4c=j8+![!!6-3&L@NF$J1_7A$N $B!ZLdBjE@![!!IBM}3XE*?GCG!"NI0-@-!"<#NEJ}?K$K$D$$$F(B |
$B$B%k!<%Z(B$B!"(B$B |
|
$B#6#2#5!'(B$B4c5eFb $BBg:eBg3XBg3X1!0e3X8&5f2J!!IBBVIBM}3X(B(1)$B!"!!4c2J(B(2) $BF#EDLP |
|
---|---|
$BEjI<7k2L(B 5$B!!(B $B!!!!!!!!(B |
Mesectodermal leiomyoma |
$B8!F$7k2L(B |
Mesectodermal leiomyoma |
$B>INc(B | $B#1#0:PBe8eH>!"=w@-(B |
$B7P2a(B |
$B!Z $B!Z4{1}Nr!"2HB2Nr![FC5-;v9`L5$7(B $B!Z8=IBNr![H>G/A0:"$h$j1&4cI!B&7kKl$K=<7l$rG'$a$?!%1&>eJ}$NL8;k$,=P8=$7!$;kLn>c32$,5^B.$K?J9T$7$?!%(B $B#2%v7n8e!$LVKlGmN%$rH<$&1&LSMMBN $B!Z2hA|=j8+![(BMRI$B$K$F4c5e$K(BT1 high, T2 iso-density$B$N $B!Z%^%/%m=j8+![L.MmKl2<$K6-3&L@NF!$CF@-9E!$(B 20x20x16mm$B$NGr?'$N |
$B$B%^%/%m(B$B!"(B$B!_(B20$B!"(B$B!_(B40$B!"(B$B!_(B400 |
|
$B#6#2#6!'G>FbB?Ac@-IBAc$r<($75^B.$K?@7P>I>u$,0-2=$7$?#1Nc(B $BF`NI8)N)0e2JBg3X!!IBM}IBBV3X(B $BCfB<8wMx!"@PED1QOB!"EgED7<;J!">.@>!!EP(B |
|
---|---|
$BEjI<7k2L(B $B!!(B9$B!!(B $B!!(B |
Astrocytoma |
$B8!F$7k2L(B |
Inflammatory demyelinating leucoencephalopathy |
|
30$B:MBeA0H>!"CK@-(B |
$B7P2a(B |
$B!Z4{1}Nr![2HB2Nr!'FC5-$9$Y$-;v$J$7(B $B!Z8=IBNr![K\G/=i=\$h$jITL2$H$J$j!"0UM_$HH=CGNO$NDc2<$r $B!ZF~1!8e7P2a![F~1!D>8e$+$i?@7P>I>u$N0-2=!J(B2/5$BDxEY$N1&>e2<;hKcac!"7P8}@] $B!Z2hA|=j8+![E>1!MbF|$N(BMRI$B$G!"N>B&BgG>H>5eHi $B!ZLdBjE@![IBM}AH?%?GCG(B
|
$BIMAGE001$B!"(BIMAGE002$B!"(BIMAGE003$B!"(BIMAGE004 |
|
$B#6#2(B7$B!'(B$BG>FbB?H/IBJQ$N0l>.;yNc(B $BBg:e;TN)Am9g0eNE%;%s%?! $B0f>e!!7r(B1$B!K!"jj!!1Q^,(B1$B!K!">.NSMG | |
---|---|
$BEjI<7k2L(B $B!!(B7$B!!(B $B!!!!(B |
Malignant Lymphoma |
$B8!F$7k2L(B |
Malignant Lymphoma, anaplastic large cell type |
$B>INc(B | 10$B:PBeA0H>!"=w;y(B |
$B7P2a(B |
$B!Z $B!Z8=IBNr![(B $B!Z2hA|=j8+![!J(BMRI$B!K(B $B!JI8K\$,>.$5$$$?$a!"AH?%A|Ey$O%$%s%?!<%M%C%H8x3+2hA|$r8f;2>H2<$5$$!K(B |
$BMRI$B!"(BHE1$B!"(BHE2$B!"(BHE3 |
|